Seller record · joinsprouthealth.com

Sprout Health

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 1 of 8 criteria. S5, analytical documentation: The NAD+ page calls the drug third party lab tested with no document behind it. No certificate or lot report appears on the product pages, the terms or the refund policy.

At a glance

Sprout Healthjoinsprouthealth.com

7/8criteria passed

Price: Semaglutide $299, tirzepatide $349 a month
Sells: compounded semaglutide, compounded tirzepatide, and 3 more
FDA letters: 1 on file

Unpaid link. Sprout Health does not pay the site. Funding

Visit Sprout Health See all eight dispositions

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide, tirzepatide and NAD+ injections, and brand Wegovy and Zepbound. It names two pharmacies in its terms, and an FDA warning letter from September 2025 cites its claim that GLP-1 drugs are FDA-approved.

Operating entity Sprout Health Partners LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	joinsprouthealth.com, joinsprouthealth.com/terms-and-conditions
S2	Prescription gating	PASS	intake.joinsprouthealth.com
S3	Pharmacy identification	PASS	joinsprouthealth.com/terms-and-conditions
S4	Compounding disclosure	PASS	joinsprouthealth.com/join-glp1-org, joinsprouthealth.com/tirzepatide-weightloss
S5	Analytical documentation	FAIL	joinsprouthealth.com/start-nad-plus
S6	Business address	PASS	joinsprouthealth.com/contact, joinsprouthealth.com/terms-and-conditions
S7	Price disclosure	PASS	joinsprouthealth.com/join-glp1-org, joinsprouthealth.com/tirzepatide-weightloss, joinsprouthealth.com/start-nad-plus
S8	Enforcement status	PASS	fda.gov, letter 715879

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSAn independent licensed provider reviews each health history and decides whether to prescribe, and the terms name MD Integrations, a physician network, as the clinical partner.Source: joinsprouthealth.com, joinsprouthealth.com/terms-and-conditions.

S2PASSEvery order button opens a medical questionnaire that first asks the weight loss goal, and no cart exists; the questions state that a provider evaluation is required before any prescription.Source: intake.joinsprouthealth.com.

S3PASSThe terms name two pharmacies among the outside services, Foothills Pharmacy and Promise Pharmacy, each with an email address and no street address or state.Source: joinsprouthealth.com/terms-and-conditions.

S4PASSCompounded GLP-1 and GIP/GLP-1 are not approved by the FDA, printed in the footer of every page, and each product page labels the drug compounded and not FDA-approved.Source: joinsprouthealth.com/join-glp1-org, joinsprouthealth.com/tirzepatide-weightloss.

S5FAILThe NAD+ page calls the drug third party lab tested with no document behind it. No certificate or lot report appears on the product pages, the terms or the refund policy.Source: joinsprouthealth.com/start-nad-plus.

S6PASSSprout Health Partners LLC at 1042 El Camino Real, Encinitas, CA 92024, printed in the footer of every page, while the terms and privacy policy spell the company Sprouth Health Partners LLC.Source: joinsprouthealth.com/contact, joinsprouthealth.com/terms-and-conditions.

S7PASSCompounded semaglutide at $299 a month and tirzepatide at $349 a month, each with a lower first month of $149 and $199, and NAD+ at $199 for the first month, then $249 every 4 weeks.Source: joinsprouthealth.com/join-glp1-org, joinsprouthealth.com/tirzepatide-weightloss, joinsprouthealth.com/start-nad-plus.

S8PASSFDA warning letter 715879, September 2025, names Sprout Health Partners LLC and joinsprouthealth.com over a website claim that GLP-1 medications are FDA-approved, which it calls false or misleading for compounded semaglutide and tirzepatide. No FDA action has halted the business, and the seller still trades.Source: fda.gov, letter 715879.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, compounded NAD+ injection, brand Wegovy, brand Zepbound.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells NAD+

Enforcement documents on file: 1 warning letter

FDA warning letter 715879, issued September 2025, to Sprout Health Partners LLC dba Sprout HealthA claim on joinsprouthealth.com that GLP-1 medications are FDA-approved is false or misleading for its compounded semaglutide and tirzepatide.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Unpaid link. Sprout Health does not pay the site, and nothing is earned when it is used. Funding.

Visit Sprout Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.